Schedule 13D ownership disclosure

Nautilus Biotechnology, Inc.

Common stock, par value $0.0001 per share · CUSIP: 63909J108

Event date: 2025-03-03

Filing-level shares
22,263,911.00
Percent of class
17.4%
  • Parag MallickReported CIK 0001857948

    Shares: 22,263,911.00 · Class: 17.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001808805-25-000033
Form type
SCHEDULE 13D/A
Filer
Mallick Parag
CIK
CIK 1857948
Filed
Mar 05, 2025
Reporting period
Mar 03, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub